← Back to Search

High Fiber Diet + High-Intensity Exercise for Heart Failure

N/A
Recruiting
Led By Siddhartha S Angadi, PhD
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
NYHA class II-III symptoms
≥40 years of age
Must not have
Uncompensated heart failure
Acute pulmonary embolus
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether 4 weeks of exercise training, eating the DASH diet, or a combination of the two can improve clinical outcomes in people with HFpEF.

Who is the study for?
This trial is for people over 40 with heart failure where the heart pumps normally (HFpEF) and mild to moderate symptoms. They must be cleared by a doctor for exercise and the DASH diet, fully vaccinated against COVID-19, and not have had recent severe heart issues or conditions that prevent them from exercising or following the diet.
What is being tested?
The study tests if high-intensity interval exercise, a healthy eating plan called the DASH diet, or both combined can improve health in those with HFpEF. Participants will follow their assigned programs for four weeks to see which method works best.
What are the potential side effects?
Potential side effects may include muscle soreness or injury from intense exercise. The DASH diet is generally safe but could cause changes in bowel habits due to increased fiber intake.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have moderate to severe heart symptoms.
Select...
I am 40 years old or older.
Select...
I am fully vaccinated against COVID-19.
Select...
I have been diagnosed with a type of heart failure where the heart muscle pumps normally.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have heart failure that is not well-managed.
Select...
I have had a recent blood clot in my lung.
Select...
My high blood pressure is not under control.
Select...
I have severe symptoms from a narrowed heart valve.
Select...
I have been diagnosed with acute myocarditis.
Select...
I have unstable chest pain.
Select...
I have severe heart symptoms that limit my daily activities.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
VO2peak
Secondary study objectives
Blood pressure
Body Composition
Carotid-Femoral Pulse Wave Velocity
+9 more
Other study objectives
Endothelin-1
Fasting Blood Glucose
Inflammation
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Group I: High Intensity Interval ExerciseExperimental Treatment1 Intervention
Enrolled patients will perform supervised exercise on 3 nonconsecutive days of the week for 4 weeks.
Group II: Exercise + DASH DietExperimental Treatment1 Intervention
Enrolled subjects will undergo both the exercise training visits and be provided with the DASH diet.
Group III: Dietary Approaches to Stop Hypertension (DASH) DietExperimental Treatment1 Intervention
Enrolled patients will have all of their food prepared for them by a registered dietician for the duration of the study period. The diet will consist of a high fiber content DASH diet.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
High Intensity Interval Exercise
2021
N/A
~90

Find a Location

Who is running the clinical trial?

University of VirginiaLead Sponsor
782 Previous Clinical Trials
1,315,666 Total Patients Enrolled
12 Trials studying Heart Failure
1,539 Patients Enrolled for Heart Failure
Grain Foods FoundationUNKNOWN
1 Previous Clinical Trials
120 Total Patients Enrolled
Siddhartha S Angadi, PhDPrincipal InvestigatorUniversity of Virginia
3 Previous Clinical Trials
89 Total Patients Enrolled

Media Library

Dietary Approaches to Stop Hypertension (DASH) Diet Clinical Trial Eligibility Overview. Trial Name: NCT05236413 — N/A
Heart Failure Research Study Groups: Dietary Approaches to Stop Hypertension (DASH) Diet, High Intensity Interval Exercise, Exercise + DASH Diet
Heart Failure Clinical Trial 2023: Dietary Approaches to Stop Hypertension (DASH) Diet Highlights & Side Effects. Trial Name: NCT05236413 — N/A
Dietary Approaches to Stop Hypertension (DASH) Diet 2023 Treatment Timeline for Medical Study. Trial Name: NCT05236413 — N/A
~7 spots leftby Aug 2025